Details for: CL0001044

Cell ID: CL0001044

Cell Name: effector CD4-positive, alpha-beta T cell

Description: This cell type is compatible with the HIPC Lyoplate markers for 'effector CD4+ T cell'. The functional characteristics of this cell type currently undefined in CL, which affects its proper placement within the hierarchy.

Synonyms: effector CD4-positive, alpha-beta T lymphocyte, effector CD4-positive, alpha-beta T-cell, effector CD4-positive, alpha-beta T-lymphocyte, effector CD4+ T cell

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for effector CD4-positive, alpha-beta T cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for effector CD4-positive, alpha-beta T cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for effector CD4-positive, alpha-beta T cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for effector CD4-positive, alpha-beta T cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  effector CD4-positive, alpha-beta T cell (CL0001044)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [effector CD4-positive, alpha-beta T cell](/details-cell/CL0001044) is a terminally differentiated lymphocyte central to the adaptive immune response. **Overall**, its gene significance profile is dominated by markers essential for T-cell identity and signaling, including components of the T-cell receptor complex ([TRBC1](/details-gene/28639), [CD3G](/details-gene/917), [CD3D](/details-gene/915), [CD3E](/details-gene/916)) and antigen interaction ([B2M](/details-gene/567)). Critically, its "effector" nature is underscored by the high specificity of genes directly involved in cytotoxicity, such as [GZMA](/details-gene/3001) (Granzyme A) and [PRF1](/details-gene/5551) (Perforin 1). The data suggest this cell is a highly active, metabolically engaged lymphocyte poised to execute direct cytotoxic functions. ## Key Characteristics and Function Analysis of the top markers reveals several core functional clusters that define the [effector CD4-positive, alpha-beta T cell](/details-cell/CL0001044). * **T-Cell Lineage and Signaling:** The identity of this cell is unambiguously established by the high cell significance index ([CSI](/glossary/csi)) scores for genes encoding the T-cell receptor and its associated signaling apparatus. These include the T-Cell Receptor Beta Constant 1 ([TRBC1](/details-gene/28639)) and multiple subunits of the CD3 complex ([CD3G](/details-gene/917), [CD3D](/details-gene/915), [CD3E](/details-gene/916)). The pan-leukocyte marker [PTPRC](/details-gene/5788) (CD45) is also a top marker, consistent with its hematopoietic origin. The presence of [CD8A](/details-gene/925) as a significant marker in a cell type defined as CD4-positive is notable and may indicate a specialized cytotoxic subset. * **Cytotoxic Effector Program:** A key feature is the strong signature for genes mediating T-cell cytotoxicity. The high specificity of [GZMA](/details-gene/3001) and [PRF1](/details-gene/5551) suggests this cell is primed to directly kill target cells by inducing apoptosis. This is further supported by the specific expression of [CST7](/details-gene/8530) (Cystatin F), a cysteine protease inhibitor known to be expressed in cytotoxic lymphocytes. * **High Metabolic and Biosynthetic Activity:** The cell profile indicates a state of high metabolic activity, consistent with an activated effector state. Significant markers include eukaryotic translation elongation factors [EEF1B2](/details-gene/1933) and [EEF1D](/details-gene/1936), suggesting a high capacity for protein synthesis required for the production of effector molecules like cytokines and granzymes. * **Distinct Metabolic State:** The anti-marker profile provides strong evidence for a specific metabolic configuration. A striking number of genes encoding components of the mitochondrial electron transport chain are significantly down-regulated, including [NDUFA4](/details-gene/4697), [COX6C](/details-gene/1345), [ND1](/details-gene/4535), and [COX2](/details-gene/4513). This coordinated suppression of oxidative phosphorylation machinery is a classic hallmark of the Warburg effect (aerobic glycolysis), a metabolic state preferentially used by activated effector lymphocytes to support rapid energy production and biomass accumulation. ## Clinical Significance and Contextual Roles **Overall**, the gene profile of the [effector CD4-positive, alpha-beta T cell](/details-cell/CL0001044) highlights its critical role in immune surveillance and host defense, particularly against intracellular pathogens and tumors. The clinical importance of its core functions is underscored by severe immunodeficiency syndromes linked to mutations in its defining genes. For example, mutations in [PRF1](/details-gene/5551) are a primary cause of familial hemophagocytic lymphohistiocytosis (FHL), a life-threatening disease of excessive immune activation resulting from an inability to clear antigenic stimuli. Likewise, defects in the CD3 complex genes ([CD3G](/details-gene/917), [CD3D](/details-gene/915), [CD3E](/details-gene/916)) lead to severe combined immunodeficiency (SCID), characterized by a profound lack of T-cell function. The potent cytotoxic signature ([GZMA](/details-gene/3001), [PRF1](/details-gene/5551)) suggests this cell is a key player in anti-tumor immunity and the clearance of virally infected cells. The simultaneous high specificity for [CD8A](/details-gene/925) within a CD4-positive designated population may point towards the existence of cytotoxic CD4+ T cells (CD4-CTLs), a subset implicated in controlling chronic viral infections like HIV and in cancer immunotherapy contexts. ## Potential Mechanisms and Research Directions 1. **Hypothesis: The anti-marker signature for mitochondrial genes reflects a metabolic commitment to aerobic glycolysis essential for effector function.** The coordinated negative significance of numerous genes from multiple mitochondrial respiratory complexes (e.g., [NDUFA4](/details-gene/4697), [COX6C](/details-gene/1345), [UQCRB](/details-gene/7381)) strongly indicates a systemic suppression of oxidative phosphorylation. We hypothesize that this metabolic shift to glycolysis is not merely a consequence of activation but a prerequisite for sustaining the high biosynthetic demands (evidenced by high CSI for [EEF1B2](/details-gene/1933) and [EEF1D](/details-gene/1936)) and rapid execution of the cytotoxic program characteristic of this cell. * **Surprising Findings:** The breadth of negatively significant mitochondrial genes across Complexes I, III, and IV is remarkable. This suggests a highly regulated, top-down suppression of the entire oxidative phosphorylation pathway, rather than a bottleneck at a single complex, providing robust evidence for a fundamental metabolic reprogramming. * **Testable Questions:** Does the targeted inhibition of key glycolytic enzymes (e.g., hexokinase-2) more potently abrogate the cytotoxic capacity and effector cytokine production of [effector CD4-positive, alpha-beta T cells](/details-cell/CL0001044) than the inhibition of mitochondrial ATP synthase? 2. **Hypothesis: The co-occurrence of CD4 lineage identity with a strong [CD8A](/details-gene/925) signature identifies this population as cytotoxic CD4+ T lymphocytes (CD4-CTLs).** The canonical view separates T cells into CD4+ helpers and CD8+ killers. The finding that [CD8A](/details-gene/925) is a significant positive marker for a cell defined as "CD4-positive," especially in conjunction with a robust cytotoxic gene program ([GZMA](/details-gene/3001), [PRF1](/details-gene/5551)), suggests this dataset has captured a non-canonical CD4-CTL subset. These cells may adopt features of cytotoxic T lymphocytes while retaining a CD4+ identity, potentially playing a unique role in immunity. * **Surprising Findings:** The high statistical significance (CSI of 8.67) for [CD8A](/details-gene/925) in a CD4+ T cell context is highly unusual. This finding challenges the simple CD4/CD8 dichotomy and points towards a more complex reality of T-cell differentiation and plasticity, where lineage-defining markers may be more fluid than traditionally appreciated. * **Testable Questions:** Can dual-protein staining by flow cytometry or single-cell RNA sequencing on activated T-cell populations confirm a subset of cells that co-express CD4 protein, CD8A protein, and intracellular Granzyme A, and does the frequency of this population increase following specific viral or tumor antigen stimulation?